Envestnet Asset Management’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-5,311
Closed -$136K 2984
2018
Q2
$136K Sell
5,311
-6,005
-53% -$140K ﹤0.01% 1870
2018
Q1
$228K Sell
11,316
-5,339
-32% -$125K ﹤0.01% 1524
2017
Q4
$334K Buy
16,655
+3,550
+27% +$69.8K ﹤0.01% 1656
2017
Q3
$271K Buy
13,105
+1,644
+14% +$27.8K ﹤0.01% 1708
2017
Q2
$169K Sell
11,461
-24
-0.2% -$400 ﹤0.01% 1929
2017
Q1
$183K Buy
11,485
+2,820
+33% +$40.7K ﹤0.01% 1957
2016
Q4
$108K Sell
8,665
-13,718
-61% -$255K ﹤0.01% 2156
2016
Q3
$627K Buy
22,383
+4,889
+28% +$164K ﹤0.01% 1446
2016
Q2
$612K Buy
17,494
+2,631
+18% +$82.7K ﹤0.01% 1558
2016
Q1
$407K Buy
14,863
+3,376
+29% +$99.4K ﹤0.01% 1733
2015
Q4
$393K Buy
11,487
+9,385
+446% +$293K ﹤0.01% 1700
2015
Q3
$60K Buy
+2,102
New +$89.9K ﹤0.01% 2565

Other funds holding DPLO

Envestnet Asset Management's DPLO Position: Q3 2018 in Review

Envestnet Asset Management sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q3 2018, closing a stake of 5,311 shares — an estimated $136K sold.

Envestnet Asset Management first reported a position in DPLO in Q3 2015 and held it in 12 quarters. The position peaked at $627K in Q3 2016. 178 funds tracked by Wall St. Rank hold DPLO as of Q3 2018.

  • Envestnet Asset Management reported no remaining DIPLOMAT PHARMACY, INC. position as of Q3 2018 after selling out during the quarter.
  • Envestnet Asset Management sold 5,311 DIPLOMAT PHARMACY, INC. shares in Q3 2018, an estimated $136K.
  • Envestnet Asset Management first reported a position in DIPLOMAT PHARMACY, INC. in Q3 2015 and held it in 12 quarters.
  • Envestnet Asset Management's DIPLOMAT PHARMACY, INC. position peaked at $627K in Q3 2016.
  • 178 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q3 2018.

Based on Envestnet Asset Management's 13F filing for Q3 2018, filed 14 Nov 2018.